Curriculum Vitae

DR. WONG CHEE KUAN

Medical Lecturer
  • Department of Medicine
    Faculty of Medicine
  • ckwong
  • 0379492867

BIOGRAPHY

Dr. Wong Chee Kuan is a distinguished medical lecturer and consultant pulmonologist at the Universiti Malaya, specializing in respiratory diseases such as tuberculosis, COVID-19 pneumonia, asthma, chronic obstructive pulmonary disease (COPD) and lung cancer. He currently serves as the Head of the Division of Respiratory Medicine and the Chairman of the UMMC Tuberculosis (TB) Committee, where he has played a pivotal role in advancing the understanding and management of respiratory diseases. Dr. Wong earned his medical degree from Universiti Kebangsaan Malaysia (UKM) and obtained Membership of the Royal College of Physician (MRCP) in the United Kingdom. He further completed his fellowship in Respiratory Medicine at Universiti Malaya, cementing his expertise in the field.

Wth a career spanning over a decade, Dr. Wong has made significant contributions to clinical research, medical education, and patient care. He is an active researcher and has publised extensively in high-impact journals, addressing critical issues such as severe asthma, COPD, and long-term effects of COVID-19. His research efforts are supported by national and international funding bodies, including the World Health Organization (WHO) and the National Institute for Health Research (NIHR). Dr. Wong has led multiple clinical trials, contributing to advancement in respiratory medicine.

In addition to his research, Dr. Wong is a passionate educator, supervising postgraduate students and mentoring future healthcare professionals. He has also contributed to the development of national TB clinical practice guidelines and serves on various professional committees, including the Malaysian Thoracic Society. A sought-after speaker and panelist, he frequently shares his expertise at conferences and workshop, both locally and internationally. Dr. Wong is commited to improving the quality of life for patients with respiratory diseases and aims to contribute toward eradicating tuberculosis by 2035 through his leadership, research, and advocacy.

 

AREAS OF EXPERTISE

  • INFECTIOUS/ COMMUNICABLE DISEASES
    Medical And Health Sciences, Clinical Sciences, Clinical Practice
  • RESPIRATORY MEDICINE
    Medical And Health Sciences, Clinical Sciences, Clinical Practice
  • HEALTH EQUITY
    Economic Empowerment, Economic Equity
  • QUALITY AND ACCESSABLE HEALTH SYSTEM
    Human And Societal Resilency, Basic Human And Social Needs
  • PERSONNEL MOBILITY AND PUBLIC-PRIVATE COLLABORATIONS
    Advancement Of Knowledge And Learning, Knowledge Flows And Exploitation

ACADEMIC QUALIFICATION

  • MRCP
    Royal College of Physicians of Edinburgh, United Kingdom
  • MD, (Medicine)
    Universiti Kebangsaan Malaysia (UKM)

ADMINISTRATIVE DUTIES

  • Task Force Leader
    01 Jan 2024 - 31 Dec 2025 (University Malaya)
  • Committee Members
    31 Oct 2022 - 31 Oct 2024 (University Malaya)
  • Head of Unit
    20 Oct 2022 - 20 Oct 2024 (Department)
  • Head of Respiratory Medicine Unit
    20 Oct 2022 - 20 Oct 2024 (Department)
  • Committee Members
    04 Mar 2022 - 04 Mar 2024 (University Malaya)
  • Chairman
    01 Jan 2022 - 31 Dec 2023 (Department of Medicine, Faculty of Medicine)
  • Chairman
    01 Jan 2022 - 31 Dec 2023 (Department of Medicine, Faculty of Medicine)
  • Head of Unit
    01 Jan 2023 - 30 Dec 2023 (Department of Medicine, Faculty of Medicine)
  • Organising committee member and chairperson of case based discussion
    26 May 2023 - 28 May 2023 (International)
  • Head of Respiratory Unit, Department of Medicine.
    19 Oct 2020 - 31 Oct 2022 (Department)
  • Committee Members
    08 Jul 2022 - 08 Jul 2022 (University Malaya)
  • Chairman
    01 Dec 2017 - 30 Nov 2019 (Department of Medicine, Faculty of Medicine)

MEMBERSHIPS

  • ASIAN PACIFIC SOCIETY OF RESPIROLOGY, MEMBER
    Since 2020 (International)
  • EUROPEAN RESPIRATORY SOCIETY (ERS), MEMBER
    2017 to 2024 (International)
  • MALAYSIAN THORACIC SOCIETY, MEMBER
    Since 2012 (National)
  • AHLI JAWATANKUASA PEMANTAUAN DAN PENCEGAHAN PENYAKIT TUBERCULOSIS (TB) DIKALANGAN STAF DI PPUM, MEMBER
    2021 to 2022 (National)
  • JAWATANKUASA HOME RESPIRATORY EQUIPMENT LOAN PROGRAMME PPUM, MEMBER
    2021 to 2022 (National)
  • SPECIALIST REGISTRY FOR INTERNAL MEDICINE AND RESPIRATORY MEDICINE, MEMBER
    2018 to 2022 (National)
  • JAWATANKUASA PENILAIAN TEKNIKAL BAGI: TAWARAN BAGI MEMBEKAL UBAT-UBAT RESPIRATORI 2, MEMBER
    2021 to 2021 (National)
  • JAWATANKUASA TASKFORCE COVID-19 PUSAT PERUBATAN UNIVERSITI MALAYA, MEMBER
    2021 to 2021 (National)
  • OHS KOORDINATOR COVID-19, MEMBER
    2021 to 2021 (National)
  • THE MALAYSIAN THORACIC SOCIETY INHALER EDUCATION AND TRAINING STEERING COMMITTEE 2020-2021, COMMITTEE MEMBER
    2020 to 2021 (National)

AWARD AND STEWARDSHIP

  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2022 (University)
  • Anugerah Perkhidmatan Cemerlang
    University of Malaya, 2019 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2019 (University)

PUBLICATIONS

Article in Journal
WoS
  1. Balakrishnan, Vimala; Ramanathan, Ghayathri; Zhou, Siyi; Wong, Chee Kuan (2024). Optimized support vector regression predicting treatment duration among tuberculosis patients in Malaysia, MULTIMEDIA TOOLS AND APPLICATIONS. . doi:10.1007/s11042-023-16028-y
  2. Tan, Siow-Hooi; Wong, Chee-Kuan; Yap, Yee-Yann; Tan, Siow-Kian (2024). Factors influencing telemedicine adoption among physicians in the Malaysian healthcare system: A revisit, DIGITAL HEALTH. 10. doi:10.1177/20552076241257050
  3. Atiya, N.; Gunn, C. L. Q.; Lim, B. W. W.; Ser, G. T. Z.; Mahendran, H.; Ong, J. B. S. Q.; Ong, L. B. S. Y.; Kueh, M. T. W.; Wong, C. K. (2023). PATTERNS AND TRENDS IN FIRST-LINE ANTI-TUBERCULOSIS DRUG RESISTANCE IN A MAJOR MALAYSIAN TERTIARY TEACHING HOSPITAL OVER A 4-YEAR PERIOD (2017-2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 134, S17-S17. doi:10.1016/j.ijid.2023.05.060
  4. Chan, Soo Chin; Beh, Hooi Chin; Nathan, Jayakayatri Jeevajothi; Sahadeevan, Yasothai; Engkasan, Julia Patrick; Chuah, Su Yee; Pek, Eu Way; Abdullah, Nurdiana; Wong, Chee Kuan; Hussein, Norita; Suhaimi, Anwar; Hanafi, Nik Sherina; Mirza, Fatim T.; Yatim, Saari Mohamad; Pinnock, Hilary; William, Sian; Khoo, Ee Ming (2023). Pulmonary rehabilitation capacity building through a teach-the-teacher programme A Malaysian experience, JOURNAL OF GLOBAL HEALTH. 13. doi:10.7189/jogh.13.03047
  5. Kee, Yan Shen; Wong, Chee Kuan; Aziz, Muhammad Anis Abdul; Zakaria, Mohd Idzwan; Shaarif, Fatimah Mohd; Ng, Kee Seong; Liam, Chong Kin; Pang, Yong Kek; Khoo, Ee Ming (2023). 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital, INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. 18, 2623-2631. doi:10.2147/COPD.S429108
  6. Liam, Chong Kin; Yew, Chian Yih; Pang, Yong Kek; Wong, Chee Kuan; Poh, Mau Ern; Tan, Jiunn Liang; Soo, Chun Ian; Loh, Thian Chee; Chin, Ka Kiat; Munusamy, Vijayan; Liam, Yong Sheng; Ibrahim, Nur Husna (2023). Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers, BMC CANCER. 23(1). doi:10.1186/s12885-023-11156-y
  7. Sia, Leng Cheng; Pang, Yong-Kek; Wong, Chee Kuan; Soo, Chun Ian; Ibrahim, Nur Husna; Munusamy, Vijayan; Loh, Thian Chee; Chin, Ka Kiat; Poh, Mau Ern; Tan, Jiunn Liang; Liam, Chong-Kin (2023). Symptomatic prolonged viral shedding in long COVID - Our experience with remdesivir, EUROPEAN RESPIRATORY JOURNAL. 62. doi:10.1183/13993003.congress-2023.PA3415
  8. Soo, Chun Ian; Munusamy, Vijayan; Sia, Leng Cheng; Ibrahim, Nur Husna; Loh, Thian Chee; Tan, Jiunn Liang; Chin, Ka Kiat; Wong, Chee Kuan; Poh, Mau Ern; Pang, Yong Kek; Liam, Chong Kin (2023). Diagnostic yield and utility of endobronchial ultrasound-guided transmediastinal cryobiopsy in pulmonary disease: Novel insights from an early retrospective single-center experience in Malaysia, RESPIROLOGY. 28, 366-367
  9. Soo, Chun Ian; Pek, Eu Way; Capelle, David Paul; Wong, Chee Kuan; Yong, Mei Ching; Loh, Ee Chin; Shahrizaila, Nortina (2023). Tolerance to non-invasive ventilation support in patients with amyotrophic lateral sclerosis: Our early experience, RESPIROLOGY. 28, 317-317
  10. Soo, Chun Ian; Pek, Eu Way; Capelle, David Paul; Yong, Chee Shion; Wong, Chee Kuan; Shahrizaila, Nortina; Loh, Ee Chin (2023). Modified interface for non-invasive ventilation in a patient with amyotrophic lateral sclerosis with limited upper limb function, RESPIROLOGY. 28, 316-317
  11. Soo, Chun Ian; Poon, Khai Vern; Ayub, Atiqah; You, Hui Wen; Tan, Cai Xian; Loh, Jia Juin Kenneth; Eng, Chai Hui Carolyn; Sia, Leng Cheng; Ibrahim, Nur Husna; Chin, Ka Kiat; Loh, Thian Chee; Munusamy, Vijayan; Poh, Mau Ern; Tan, Jun Liang; Pang, Yong Kek; Liam, Chong Kin; Wong, Chee Kuan (2023). Methyprednisolone versus dexamethasone for severe COVID-19 infection: A retrospective comparative analysis of our early experience, RESPIROLOGY. 28, 92-92
  12. Soo, Chun Ian; Sia, Leng Cheng; Munusamy, Vijayan; Ibrahim, Nur Husna; Chin, Ka Kiat; Loh, Thian Chee; Tan, Jiunn Liang; Poh, Mau Ern; Wong, Chee Kuan; Pang, Yong Kek; Liam, Chong Kin (2023). Tissue coagulum clot cellblock from EBUS-TBNA for the diagnosis of necrotic mediastinal lesions, RESPIROLOGY. 28, 369-370
  13. Soo, Chun Ian; Sia, Leng Cheng; Munusamy, Vijayan; Ibrahim, Nur Husna; Chin, Ka Kiat; Loh, Thian Chee; Tan, Juinn Liang; Low, Sook Ling; Poh, Mau Ern; Wong, Chee Kuan; Pang, Yong Kek; Liam, Chong Kin (2023). Tissue coagulum clot cellblock from EBUS-TBNA for the diagnosis of necrotic lung and mediastinal lesions., EUROPEAN RESPIRATORY JOURNAL. 62. doi:10.1183/13993003.congress-2023.PA477
  14. Wong, Chee Kuan; Ng, Kee Seong; Choo, Sarah Qian Rou; Lee, Choon Jiat; Teo, Yik Pheng; Liew, Su May; Chinna, Karuthan; Khoo, Ee Ming; Ng, Wei Leik; Tok, Peter Seah Keng; Kee, Yan Shen; Chiang, De Min (2023). Factors associated with all-cause mortality in tuberculosis patients in a Malaysian tertiary hospital, JOURNAL OF INFECTION IN DEVELOPING COUNTRIES. 17(8), 1138-+. doi:10.3855/jidc.16967
  15. Wong, Chee Kuan; Teh, Chui Jiun; Low, Kah Seng; Chin, Ka Kiat; Soo, Chun Ian; Liam, Chong Kin; Pang, Yong Kek; Sia, Leng Cheng; Loh, Thian Chee; Ibrahim, Nur Husna; Poh, Mau Ern; Tan, Jiunn Liang; Munusamy, Vijayan (2023). Identifying the prevalence of severe asthma in a Malaysian tertiary hospital, RESPIROLOGY. 28, 99-99
  16. Sia, L. C.; Wong, C. K.; Ooi, N. Z. M.; Chan, W. Y.; Pang, Y.; Liam, C. K.; Soo, C. I.; Tan, J. L.; Poh, M. E.; Chin, K. K.; Loh, T. C.; Ibrahim, N. H.; Munusamy, V. (2022). Persistent respiratory failure in severe COVID-19 patients - A tertiary centre experience in Kuala Lumpur, Malaysia., EUROPEAN RESPIRATORY JOURNAL. 60. doi:10.1183/13993003.congress-2022.2671
  17. Wong, Chee Kuan; Sia, Leng Cheng; Ooi, Noreen Zhi Min; Chan, Wai Yee; Pang, Yong-Kek (2022). Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia, PLOS ONE. 17(11). doi:10.1371/journal.pone.0276848
  18. Liam, C. K.; Yew, C. Y.; Pang, Y. K.; Wong, C. K.; Poh, M. E.; Tan, J. L.; Soo, C. I.; Loh, T. C.; Chin, K. K.; Munusamy, V.; Ibrahim, N. H. (2021). Common Oncogenic Driver Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer of Smokers and Never Smokers, JOURNAL OF THORACIC ONCOLOGY. 16(10), S1141-S1142
  19. Chong, Y. M., Sam, I. C., Chong, J. N., Bador, M. K., Ponnampalavanar, S., Omar, S. F. S., . . . Chan, Y. F. (2020). SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia. PLoS neglected tropical diseases, 14(11), 12. doi: 10.1371/journal.pntd.0008744
  20. Liam, C. K., Liam, Y. S., Poh, M. E., & Wong, C. K. (2020). Accuracy of lung cancer staging in the multidisciplinary team setting. Translational Lung Cancer Research, 9(4), 1654-1666. doi: 10.21037/tlcr.2019.11.28
  21. Liam, Chong-Kin; Liam, Yong-Sheng; Wong, Chee-Kuan (2020). Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid, TRANSLATIONAL LUNG CANCER RESEARCH. 9(2), 168-171. doi:10.21037/tlcr.2020.03.06
  22. Chai, C. S.; Liam, C. K.; Lin, O. Po; Pang, Y. K.; Ho, G. F.; Alip, A.; Wong, C. K.; Poh, M. E.; Tan, J. L. (2019). Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma, ANNALS OF ONCOLOGY. 30
  23. Chai, C. S.; Lin, O. Po; Liam, C. K.; Pang, Y. K.; Ho, G. F.; Alip, A.; Wong, C. K.; Poh, M. E.; Tan, J. L. (2019). Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib, ANNALS OF ONCOLOGY. 30
  24. Chin, Ka Kiat; Loh, Thian Chee; Chai, Chee Shee; Tan, Jiunn Liang; Poh, Mau Ern; Wong, Chee Kuan; Pang, Yong Kek; Liam, Chong Kin (2019). BALLOON DILATATION IN POST TUBERCULOSIS BRONCHIAL STENOSIS, RESPIROLOGY. 24, 227-228
  25. Poh, M. E., Liam, C. K., Mun, K. S., Chai, C. S., Wong, C. K., Tan, J. L., . . . Chin, K. K. (2019). Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy. Thoracic Cancer, 10(9), 1841-1845. doi: 10.1111/1759-7714.13156
  26. Poh, Mau Ern; Liam, Chong Kin; Mun, Kein Seong; Chai, Chee Shee; Wong, Chee Kuan; Tan, Jiunn Liang; Loh, Thian Chee; Chin, Ka Kiat (2019). Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy, THORACIC CANCER. 10(9), 1841-1845. doi:10.1111/1759-7714.13156
  27. Chai, Chee-Shee; Liam, Chong-Kin; Pang, Yong-Kek; Ng, Diana-Leh-Ching; Poh, Mau-Ern; Wong, Chee-Kuan; Tan, Jiunn-Liang (2018). QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON CLINICAL PHENOTYPES, RESPIROLOGY. 23, 129-129
ESCI
  1. Soo, Chun Ian; Ong, Diana Bee-Lan; Chin, Ka Kiat; Sia, Leng Cheng; Munusamy, Vijayan; Ibrahim, Nur Husna; Loh, Thian Chee; Tan, Jiunn Liang; Poh, Mau Ern; Wong, Chee Kuan; Pang, Yong Kek; Liam, Chong Kin (2023). Pathological complete response in an advance stage IIIB non-small cell lung cancer secondary to neoadjuvant osimertinib targeted therapy: A case report and review of literature, RESPIROLOGY CASE REPORTS. 11(7). doi:10.1002/rcr2.1181
  2. Chong, Yoong Min; Sam, I-Ching; Ponnampalavanar, Sasheela; Omar, Sharifah Faridah Syed; Kamarulzaman, Adeeba; Munusamy, Vijayan; Wong, Chee Kuan; Jamaluddin, Fadhil Hadi; Gan, Han Ming; Chong, Jennifer; Teh, Cindy Shuan Ju; Chan, Yoke Fun (2020). Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia, MICROBIOLOGY RESOURCE ANNOUNCEMENTS. 9(20). doi:10.1128/MRA.00383-20
Scopus
  1. Balakrishnan V., Ramanathan G., Zhou S., Wong C.K. (2024). Optimized support vector regression predicting treatment duration among tuberculosis patients in Malaysia, Multimedia Tools and Applications. . doi:10.1007/s11042-023-16028-y
  2. Ismail A.I., Hyder Ali I.A., Wong C.K., Ban A.Y.-L., MZ Zahrah F., Lem L.K., Abu Bakar Z., Alaga A., Omar A., Samsudin A., Lai S.L., Gandhi A. (2024). A Retrospective Study Evaluating Asthma Control in Patients on Fluticasone Propionate/Salmeterol Proactive Regular Dosing with a History of Uncontrolled Asthma, Pulmonary Therapy. . doi:10.1007/s41030-024-00278-8
  3. Soo C.I., Poon K.V., Ayub A., You H.W., Tan C.X., Loh K.J.J., Eng C.C.H., Sia L.C., Wong C.K. (2024). High-dose pulse methylprednisolone vs. dexamethasone standard therapy for severe and critical COVID-19 pneumonia: Efficacy assessment in a retrospective single-centre experience from Malaysia, Medical Journal of Malaysia. 79(1), 15-20
  4. Tan S.-H., Wong C.-K., Yap Y.-Y., Tan S.-K. (2024). Factors influencing telemedicine adoption among physicians in the Malaysian healthcare system: A revisit, Digital Health. 10. doi:10.1177/20552076241257050
  5. Tan S.-H., Yap Y.-Y., Tan S.-K., Wong C.-K. (2024). Informal caregivers perception of assistive robots in eldercare, Journal of Open Innovation: Technology, Market, and Complexity. 10(1). doi:10.1016/j.joitmc.2024.100234
  6. Chan S.C., Beh H.C., Nathan J.J., Sahadeevan Y., Engkasan J.P., Chuah S.Y., Pek E.W., Abdullah N., Wong C.K., Hussein N., Suhaimi A., Hanafi N.S., Mirza F.T., Yatim S.M., Pinnock H., William S., Khoo E.M. (2023). Pulmonary rehabilitation capacity building through a teach-the-teacher programme: A Malaysian experience, Journal of global health. 13, 03047. doi:10.7189/jogh.13.03047
  7. Kee Y.S., Wong C.K., Aziz M.A.A., Zakaria M.I., Shaarif F.M., Ng K.S., Liam C.K., Pang Y.K., Khoo E.M. (2023). 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital, International Journal of COPD. 18, 2623-2631. doi:10.2147/COPD.S429108
  8. Khuan W.H., Wong C.K. (2023). Vaping - A Precipitating Factor of Pneumothorax in A Smoker?, Malaysian Journal of Medicine and Health Sciences. 19(1), 366-368. doi:10.47836/mjmhs.19.1.46
  9. Liam C.K., Yew C.Y., Pang Y.K., Wong C.K., Poh M.E., Tan J.L., Soo C.I., Loh T.C., Chin K.K., Munusamy V., Liam Y.S., Ibrahim N.H. (2023). Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers, BMC cancer. 23(1), 659. doi:10.1186/s12885-023-11156-y
  10. Soo C.I., Ong D.B.-L., Chin K.K., Sia L.C., Munusamy V., Ibrahim N.H., Loh T.C., Tan J.L., Poh M.E., Wong C.K., Pang Y.K., Liam C.K. (2023). Pathological complete response in an advance stage IIIB non-small cell lung cancer secondary to neoadjuvant osimertinib targeted therapy: A case report and review of literature, Respirology Case Reports. 11(7). doi:10.1002/rcr2.1181
  11. Wong C.K., Ng K.S., Choo S.Q.R., Lee C.J., Teo Y.P., Liew S.M., Chinna K., Khoo E.M., Ng W.L., Tok P.S.K., Kee Y.S., Chiang D.M. (2023). Factors associated with all-cause mortality in tuberculosis patients in a Malaysian tertiary hospital, Journal of infection in developing countries. 17(8), 1138-1145. doi:10.3855/jidc.16967
  12. Wong C.K., Sia L.C., Min Ooi N.Z., Chan W.Y., Pang Y.-K. (2022). Severe COVID-19 with persistent respiratory failure A retrospective cohort study in a tertiary centre in Malaysia, PLoS ONE. 17(11 November). doi:10.1371/journal.pone.0276848
  13. Chong Y.M., Sam I.-C., Ponnampalavanar S., Omar S.F.S., Kamarulzaman A., Munusamy V., Wong C.K., Jamaluddin F.H., Gan H.M., Chong J., Teh C.S.J., Chan Y.F. (2020). Complete genome sequences of SARS-CoV-2 strains detected in Malaysia, Microbiology Resource Announcements. 9(20). doi:10.1128/MRA.00383-20
  14. Chong, Y. M., Sam, I. C., Chong, J., Kahar Bador, M., Ponnampalavanar, S., Syed Omar, S. F., . . . Chan, Y. F. (2020). SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia. Plos Neglected Tropical Diseases, 14(11), e0008744. doi: 10.1371/journal.pntd.0008744
  15. Liam C.-K., Liam Y.-S., Wong C.-K. (2020). Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid, Translational Lung Cancer Research. 9(2), 168-171. doi:10.21037/tlcr.2020.03.06
  16. Liam, C. K., Liam, Y. S., Poh, M. E., & Wong, C. K. (2020). Accuracy of lung cancer staging in the multidisciplinary team setting. Translational Lung Cancer Research, 9(4), 1654-1666. doi: 10.21037/tlcr.2019.11.28
  17. Poh M.E., Liam C.K., Mun K.S., Chai C.S., Wong C.K., Tan J.L., Loh T.C., Chin K.K. (2019). Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy, Thoracic Cancer. 10(9), 1841-1845. doi:10.1111/1759-7714.13156
Others
  1. Liam CK, Liam YS, Wong CK. (2020). Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid. Transl Lung Cancer Res. doi:10.21037/tlcr.2020.03.06
  2. Liam CK, Liam YS, Poh ME, Wong CK. Accuracy of lung cancer staging in the multidisciplinary team setting. Transl Lung Cancer Res 2020;9(4):1654-1666. doi:10.21037/tlcr.2019.11.28
  3. Poh, M.E., Liam, C.K., Wong, C.K. (2019) Epithelial to mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy. Thoracic Cancer 10(9) July 2019
Chapter in Books
  1. Tie, S.T., & Wong, C.K. (2019). Chapter 6: Guidelines on Performing Spirometry. Basic Lung Function Test for Malaysian Thoracic Society Spirometry Certification Programme. Second Edition (pp. 54-64). Kuala Lumpur, KL: Malaysian Thoracic Society.
Article in Proceeding
  1. N. Atiya, C.L.Q. Gunn, B.W.W. Lim, G.T.Z. Ser, H. Mahendran, J.B.S.Q. Ong, L.B.S.Y. Ong, M.T.W. Kueh, C.K. Wong. Patterns and trends in first-line anti-tuberculosis drug resistance in a major Malaysian tertiary teaching hospital over a 4-year period (2017-2020), International Journal of Infectious Diseases, Volume 134, Supplement 1, 2023, Page S17, ISSN 1201-9712, https://doi.org/10.1016/j.ijid.2023.05.060.
  2. O15 5: Relationship between PD L1 expression, common driver mutations and cigarette smoking in patients with non small cell lung cancer. (2021). Respirology (Carlton, Vic.), 26(S3), 42 42.
  3. O17 3: Reasons for uncontrolled asthma in patients attending a difficult to treat asthma clinic. (2021). Respirology (Carlton, Vic.), 26(S3), 46 46.
  4. P1 66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report. (2021). Respirology (Carlton, Vic.), 26(S3), 100 100.
  5. P16 117: A breathless man with a sandstorm appearance on lung computed tomography. (2021). Respirology (Carlton, Vic.), 26(S3), 500 500.
  6. P5 118: Clinical outcomes of diffuse alveolar damage and organising pneumonia in severe COVID 19 infection. (2021). Respirology (Carlton, Vic.), 26(S3), 205 206.
  7. P5 125: Abrupt cessation of systemic corticosteroid in coronavirus disease 19 (COVID 19) related secondary organizing pneumonia resulted in a rebound. (2021). Respirology (Carlton, Vic.), 26(S3), 208 208.
Other Publications
  1. . (2022, July 29). - - | Sin Chew Daily Malaysia Latest News and Headlines. Sin Chew Daily Malaysia Latest News and Headlines; . https://www.sinchew.com.my/20220729/%E8%B6%8A%E5%B0%8F%E6%9F%93%E7%83%9F%E7%98%BE%E8%B6%8A%E9%9A%BE%E6%88%92-%E9%BB%84%E4%B8%BD%E8%8A%AC%EF%BC%9A%E4%B8%80%E4%BB%A3%E4%BA%BA%E7%A6%81%E7%83%9F%E5%87%8F%E5%8C%BB%E7%96%97%E8%B4%9F%E6%8B%85/ - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  2. Wong, C. K. (2022, May 30). Radang paru-paru COVID-19 [Interview]. Ai-Hijrah. https://fb.watch/dks7A2tUpW/ - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  3. Wong, C. K. (2022b, June 30). Astro Awani: Dialog tiga penjuru: Generasi penamat rokok [Dialog]. Astro Awani. https://www.astroawani.com/video-terkini/dialog-tiga-penjuru-generasi-penamat-rokok-1976015?fbclid=IwAR1VVDDDkuge90Mq4enqiKurIKXTLyU8PD5ej3uxSLmEx5_cxOQzg3wk5T0 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  4. Wong, C. K. (2022c, August 1). All eyes on MPs as GEG vote nears. NST. https://www.nst.com.my/.../all-eyes-mps-geg-vote-nears - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  5. Wong, C. K., & Ganasan, K. (2022, May 30). Health on Traxx: World No Tobacco Day [Interview]. Traxx FM. https://www.facebook.com/TraxxfmOfficial/videos/736438637485194 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  6. Wong, C. K., & Yong, C. N. (2022, June 2). Article in Mandarin: Long Covid . The Interview. https://theinterview.asia/topic/71417/ - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  7. Goon, A. K., Razali, A., Samsudin, A., Cheng, J. T., Md Noor, K., Khoo, M. Y., Lachmanan, K. R., Mohd. Yusof, M. A., Muhamad, N. A. B., Paidi, N., Danasamy, R. S., Md Kassim, R., Jogulu, S. R., Sia, T. L. L., Wong, C. K., Wong, K. J., & Abu Bakar, Z. (2021). Clinical Practice guidelines Management of Tuberculosis. Malaysian Health Technology Assessment Section (MaHTAS). - Guidelines
  8. Wang, P. (2021, September 26). Long COVID Syndrome. China Press, 3. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  9. Wong, C. K. (2021). Multidisciplinary Management of COVID-19 Disease in University Malaya Medical Centre (UMMC): A Perspective on Acute and Post-Acute COVID-19 Care. The Internist, July 2021, 10 13. - Original Writing
  10. Wong, C. K., Mohd Hairi, F., Hassan, N., Ismail, N., Abd Hamid, M. H. N., Sayuti, M., Mohd Nor, M. A., Munusamy, V., Teo, W. S., Khuan, W. H., Mohamad, M., Othman, N. F., Rinaldi, A., & Yusoff, U. N. (2021). Development of Guidelines for The Diagnosis and Management of E-Cigarette or Vaping Use- Associated Lung Injury (EVALI) Adapted to Local Settings (pp. 1 38). Ministry of Health and University of Malaya Medical Centre. - Guidelines
  11. Wong, C. K., Mohd Hairi, F., Hassan, N., Ismail, N., Abd Hamid, M. H. N., Sayuti, M., Mohd Nor, M. A., Munusamy, V., Teo, W. S., Khuan, W. H., Mohamad, M., Othman, N. F., Rinaldi, A., & Yusoff, U. N. (2021). EVALI and Other associated Respiratory Illnesses (pp. 1 51). Ministry of Health/ University of Malaya Medical Centre. - Case Study
  12. Yong, C. N. (2021, June 17). COVID-19 pneumonia. Sin Chew Daily, 21. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  13. Cheng, M. (2020, February 12). Chronic Obstructive Pulmonary Disease. Sin Chew Daily, 19. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  14. Wong CK, & Kasmiah M. (In press). Continue at your peril. New Strait Times. Heal Section. 2020.01.28 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  15. Wong, C. K., & Ng, A. (2020, December). Difference between Asthma and COPD. Feminine, 94 97. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  16. Wong, C.K. & Marzita, A. (in press) Risiko Sesak Nafas. Mingguan. Kesihatan. 2019.06.09 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  17. Wong, C.K. (2019) Video kesedaran kesan negatif merokok dalam Penyakit Asma. Malaysian Thoracic Society - Video
  18. Wong, C.K. (2019). Malaysian Thoracic Society Spirometry Certification video. - Video

RESEARCH INTEREST

  • Tuberculosis (TB)
  • Asthma (Asthma)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Viral pneumonia (COVID, Influenza, Respiratory Syncytial Virus)

RESEARCH PROJECT

National
  1. 2022 - 2025, UM International Collaboration Grant
    Multicentered Study Comparing Knowledge, Attitude And Practice Regarding Covid-19 Among Healthcare Workers In Malaysia And Thailand ( Co-Researcher)
  2. 2023 - 2025, Bantuan Khas Penyelidikan (BKP Special)
    Malaysia?s Functional Superfood, the Tiger Milk Mushroom TM02? as an Adjunct for the Maintenance of Optimal Health ( Co-Researcher)
  3. 2023 - 2025, Bantuan Khas Penyelidikan (BKP Special)
    Investigation of The Efficacy of LiGNO TM02? (Tiger Milk Mushroom) in Modulating Immune Responses and Biomarkers in Allergic Rhinitis ( Co-Researcher)
  4. 2021 - 2024, Incyte Corporation
    A Randomized, Double Blind, Phase 3 Study of Plati-num-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non-Small Cell Lung Cancer (PODI-UM-304) ( Co-Researcher)
  5. 2022 - 2024, Allianz Malaysia Berhad
    Assessment of Post-acute COVID Syndrome (PACS) and Serological Response in Confirmed COVID-19 Patients in the University of Malaya Medical Centre ( Co-Researcher)
  6. 2022 - 2024, Johnson & Johnson Sdn Bhd
    A Phase 3, Open-label, Randomized Study of Lazertinib with Subcutaneous Amivantamab Administered via Manual Injection Compared with Intravenous Amivantamab or Amivantamab Subcutaneous On Body Delivery System in Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer After Progression on Osimertinib and Chemotherapy ( Co-Researcher)
  7. 2023 - 2024, Ligno Biotech Sdn. Bhd.
    A randomised, double-blind, placebo-controlled trial investigating the use of TM02 as adjunctive treatment in post-acute COVID-19 patients with respiratory conditions (TM02-PACOVIR) ( Principal Investigator(PI))
  8. 2019 - 2023, NONE
    UMMC TB registry ( Principal Investigator(PI))
  9. 2021 - 2022, Boehringer Ingelheim (Malaysia) sdn. bhd.
    The Area Of Interstitial Lung Disease (ILD) ( Principal Investigator(PI))
  10. 2021 - 2022, Boehringer Ingelheim (Malaysia) Sdn. Bhd.
    Pulmonary Rehabilitation program for COPD patient:, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
  11. 2020 - 2021, Hospital Taping
    One-Year Surveillance Study Of Influenza and Respiratory Syncytial Virus Infections Among Hospitalised Older Adults (>=65 Years) in Malaysia ( Co-Researcher)
  12. 2020 - 2021, International Funding
    Incidence of E-Cigarette or Vaping Product Use Associated Lung Injury (EVALI) among Severe Acute Respiratory Infections (SARI) Patients in University of Malaya Medical Centre (UMMC) ( Principal Investigator(PI))
  13. 2020 - 2021, NONE
    An audit on the efficacy of Re-Engineered Discharge program for Chronic Obstructive Pulmonary Disease patient (RED-COPD) in reducing readmission or emergency room visit for acute exacerbation of COPD in University of Malaya Medical Centre (UMMC). ( Principal Investigator(PI))
  14. 2020 - 2021, Private Funding
    Quality of life in scleroderma ILD and its association with clinical parameters in comparison with idiopathic pulmonary fibrosis. ( Principal Investigator(PI))
  15. 2021 - 2021, World Health Organisation
    Incidence of E-Cigarette or Vaping Product Use Associated Lung Injury (EVALI) among Severe Acute Respiratory Infections (SARI) patients in University Malaya Medical Centre (UMMC)., Ministry of Health Malaysia ( Co-Researcher)
  16. 2020 - 2021
    One-year hospital-based surveillance for influenza cases and Respiratory Syncytial Virus (RSV) in older adults ( 65 years) in Malaysia , Hospital Kuala Lumpur (HKL) ( Co-Researcher)
Private
  1. 2023 - 2029, AstraZeneca AB
    An Open-label, Single-arm, Phase II, Multinational, Multicentre Study to Assess the Efficacy and Safety of 5 Years of Osimertinib in Participants with Epidermal Growth Factor Receptor Mutation-Positive Stage II-IIIB Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (TARGET) ( Co-Researcher)
  2. 2022 - 2027, Novartis Corporation (Malaysia) Sdn Bhd
    A phase III randomized, controlled, open-label, multicenter, global study of capmatinib in combination with osimertinib versus platinum - pemetrexed based doublet chemotherapy in patients with locally advanced or metastatic NSCLC harboring EGFR activating mutations who have progressed on prior EGFR-TKI therapy and whose tumors are T790M mutation negative and harbor MET amplification (GEOMETRY-E) ( Co-Researcher)
  3. 2023 - 2026, Gilead Sciences, Inc.
    AN OPEN-LABEL, MULTICENTER, PHASE 2 STUDY OF SACITUZUMAB GOVITECAN COMBINATIONS IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON SMALL-CELL LUNG CANCER (NSCLC) WITHOUT ACTIONABLE GENOMIC ALTERATIONS ( Co-Researcher)
  4. 2023 - 2026, MiRXES Lab Pte Ltd
    BIOMARKER DISCOVERY IN LUNG CANCER - MALAYSIA ( Co-Researcher)
  5. 2023 - 2026, ASTRAZENECA SDN. BHD.
    A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AZD4604 TWICE DAILY FOR TWELVE WEEKS IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ASTHMA UNCONTROLLED ON MEDIUM-HIGH DOSE ICS-LABA ( Principal Investigator(PI))
  6. 2023 - 2025, AstraZeneca Sdn Bhd
    A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED 28-WEEK PHASE 3 EFFICACY AND SAFETY STUDY OF TEZEPELUMAB IN REDUCING ORAL CORTICOSTEROID USE IN ADULTS WITH ORAL CORTICOSTEROID DEPENDENT ASTHMA (SUNRISE) ( Principal Investigator(PI))
  7. 2023 - 2024, ASTRAZENECA SDN. BHD.
    A PHASE III, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TOZORAKIMAB (MEDI3506) IN PATIENTS HOSPITALISED FOR VIRAL LUNG INFECTION REQUIRING SUPPLEMENTAL OXYGEN (TILIA) ( Principal Investigator(PI))
  8. 2023 - 2023, ASTRAZENECA SDN. BHD.
    EXACERBATIONS AND THEIR OUTCOMES AMONG COPD PATIENTS IN MALAYSIA (EXACOS-MY): UNDERSTANDING THE BURDEN OF SEVERE EXACERBATIONS OF COPD AND THE ASSOCIATION BETWEEN FREQUENCY OF SEVERE EXACERBATIONS AND CLINICAL OUTCOMES IN MALAYSIA ( Principal Investigator(PI))
  9. 2023 - 2023, JOHNSON & JOHNSON SDN. BHD.
    A PHASE 1/2 STUDY EVALUATING THE SAFETY AND EFFICACY OF AMIVANTAMAB AND CETRELIMAB COMBINATION THERAPY IN METASTATIC NON-SMALL CELL LUNG CANCER ( Co-Researcher)
  10. 2022 - 2023, Private Funding - Manage by UMCARES
    Hello+@UM ( Co-Researcher)
  11. 2018 - 2021, Merck Sharp & Dohme (M) Sdn. Bhd.
    A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12-MONTH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MK-7264 IN ADULT PARTICIPANTS WITH CHRONIC COUGH (PN030) ( Principal Investigator(PI))
International
  1. 2023 - 2028, AMGEN ASIA HOLDING LIMITED
    A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF TARLATAMAB COMPARED WITH STANDARD OF CARE IN SUBJECTS WITH RELAPSED SMALL CELL LUNG CANCER AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY (DELLPHI-304) ( Co-Researcher)
  2. 2023 - 2027, Astrazeneca Sdn . Bhd
    A PHASE II, OPEN-LABEL, SINGLE-ARM, MULTI-CENTRE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OSIMERTINIB WITH AMIVANTAMAB AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION-POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (OSTARA) ( Co-Researcher)
  3. 2022 - 2026, Novartis Corporation (Malaysia) Sdn Bhd
    KontRASt-02: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS G12C mutant non-small cell lung cancer ( Co-Researcher)
  4. 2022 - 2026, International Funding
    Nihr Global Health Research Unit On Respiratory Health (respire-2) ( Co-Researcher)
  5. 2023 - 2023, National University Hospital (Singapore) Pte. Ltd.
    An observational study of afatinib 30 mg daily in patients with advanced non-small cell lung cancer (NSCLC) harbouring common EGFR mutations treated with afatinib ( Principal Investigator(PI))
  6. 2023 - 2023, Tech Observer India Pvt Ltd
    A Retrospective, Observational, Multicenter Study Evaluating Asthma Control in patients on Fluticasone propionate/Salmeterol PRD (Proactive Regular Dosing) with a history of uncontrolled asthma (MERIT) ( Principal Investigator(PI))
  7. 2020 - 2021, WORLD HEALTH ORGANIZATION (WHO)
    Incidence of E-Cigarette or Vaping Product Use Associated Lung Injury (EVALI) among Severe Acute Respiratory Infections (SARI) patients in University Malaya Medical Centre (UMMC). ( Principal Investigator(PI))
  8. 2018 - 2020, Private Funding
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Month Study to Evaluate the Efficacy and Safety of MK-7264 in Adult Participants with Chronic Cough ( Principal Investigator(PI))
University
  1. 2023 - 2025, University Grant
    Investigation of the Effect of Lignosus rhinocerus (TM02?) on Neutrophil Extracellular Traps (NETs) and Cytokine Production in Post-Acute COVID-19 Patients ( Co-Researcher)

PAPER PRESENTED

PLENARY SPEAKER
  1. Smear Positive PTB, Smear Negative PTB and TB in Special Population., UMMC TRAINING ON CLINICAL PRACTICE GUIDELINE (CPG) MANAGEMENT OF TUBERCULOSIS 4TH EDITION, Jabatan Kejururawatan dan Jawatankuasa TB PPUM (University) (09 Dec 2022 - 10 Dec 2022)
  2. Introduction Role of Asthma nurse educator in UMMC What is Asthma, Breathe Easy Program, Division of Respiratory Medicine, Nursing Department and AstraZeneca Sdn. Bhd. (University) (20 Oct 2022 - 21 Oct 2022)
  3. Overview of Re-Engineered Discharge (RED) , UMMC RE-ENGINEERED DISCHARGE IN COPD (REDCOPD) NURSE EDUCATOR WORKSHOP 1/2022, Unit Perubatan Respiratori dan Jabatan Kejururawatan (University) (06 Oct 2022 - 06 Oct 2022)
INVITED SPEAKER
  1. Case Discussions : Asthma on Adolescent and Adult Perspectives, The Malaysia National ASTHMA COPD Preceptorship, Malaysian Thoracic Society (National) (15 Nov 2024 - 15 Nov 2024)
  2. Breath of Fresh air: MASTERING COPD DIAGNOSIS,ASSESSMENT AND MANAGEMENTIN PRIMARY CARE, COPD Webinar, AstraZeneca Sdn. Bhd. and Malaysian Thoracic Society (National) (10 Oct 2024 - 10 Oct 2024)
  3. Inhalation Device Formulation Matters? Finding the Right Device to Improve Respiratory Therapy, Orient Europharma Respiratory Regional Workshop, Orient Europharma (M) Sdn Bhd (International) (24 May 2024 - 26 May 2024)
  4. Beyond Asthma Control in Severe Type 2 Asthma Management, THE 5TH HCTM RESPIRATORY UPDATE, Dept of Medicine Faculty of Medicine UKM Hospital Canselor Tuanku Muhriz (National) (21 May 2024 - 21 May 2024)
  5. Transform the Approach to Asthma Treatment for a Better Tomorrow, THE 5TH HCTM RESPIRATORY UPDATE, Dept of Medicine Faculty of Medicine UKM Hospital Canselor Tuanku Muhriz (National) (20 May 2024 - 20 May 2024)
  6. NAVIGATING THE LATEST GUIDELINES NEBULISED ANTIBIOTICS FOR BRONCHIECTASIS, THE 5TH HCTM RESPIRATORY UPDATE, Department of Medicine Faculty of Medicine UKM, Hospital Canselor Tuanku Mukhriz (National) (20 May 2024 - 20 May 2024)
  7. Diagnosis, Treatment and Current Guidelines of Latent Tuberculosis, Multidisciplinary Interactive Symposium in Immunology (MISI) 2024, Abbvie SDN BHD (National) (19 May 2024 - 19 May 2024)
  8. Charting New Horizon: The MERIT Study, Respiverse Townhall: Unlock the MERIT Control, GSK Sdn Bhd (National) (18 May 2024 - 18 May 2024)
  9. Carbon monoxide diffusion capacity (DLCO), LUNG PHYSIOLOGY MASTERCLASS SERIES 3, Respiratory Unit UiTM (National) (19 Apr 2024 - 19 Apr 2024)
  10. Pathways to Disease: What Do We Know About Type 2 Inflammation in Obstructive Airway Diseases?, Respiratory CME, HUKM, Sanofi (M) Sdn Bhd (National) (27 Feb 2024 - 27 Feb 2024)
  11. Asthma GINA 2023- the essentials., The 4th UKMMC Respiratory Update, UKMMC (National) (14 Jul 2023 - 15 Jul 2023)
  12. RED-COPD Programme, Train the Trainer RED-COPD 2.0. CLEAR THE BLOCKAGE, Division of Respiratory Medicine, Department of Medicine and Nursing Department (University) (25 May 2023 - 25 May 2023)
  13. FDC Triple Therapy in Asthma: Who Needs It?, Platinum Xpert Meeting, Minarini Sdn Bhd (National) (20 May 2023 - 20 May 2023)
  14. Approach to long COVID affecting the respiratory system, RESPIRATORY UPDATES FOR PRIMARY CARE 2023, Docquity (National) (13 May 2023 - 13 May 2023)
  15. Satndardising asthma care PRD: Optimising the goal of asthma management and improve treatment adherence., Lunch CME with RUKA: GSK,, GSK (University) (21 Mar 2023 - 21 Mar 2023)
  16. Type 2 Inflammation as seen in clinical setting: Impact on Asthma, 22nd Malaysian Society of Allergy and Immunology s (MSAI) annual event 2023, Malaysian Society of Allergy and Immunology (National) (18 Mar 2023 - 18 Mar 2023)
  17. Unlocking potential in Optimising Asthma Control, Respiverse Expert Meeting of Minds, GSK (National) (03 Mar 2023 - 03 Mar 2023)
  18. Lung function test- ATS 2022 standards on interpretation, Lung physiology masterclass 2023, Hospital UiTM (National) (03 Mar 2023 - 03 Mar 2023)
  19. Management of COPD, Ceramah Pegawai Perubatan Sarjana Perubatan Keluarga Tahun 1, RUKA, PPUM (University) (21 Feb 2023 - 21 Feb 2023)
  20. Pharmacotherapy of COPD, SEMINAR RED COPD 2023: CLEAR THE BLOCKAGE, Division of Respiratory Medicine, Department of Medicine and Nursing Department (University) (09 Feb 2023 - 09 Feb 2023)
  21. Overview of Roles of Re-Engineered Discharge (RED) COPD Educators, SEMINAR RED COPD 2023: CLEAR THE BLOCKAGE, Division of Respiratory Medicine , Medical Department and Nursing Department (University) (09 Feb 2023 - 09 Feb 2023)
  22. COPD: What Does The Guidelines Say and pharmacotherapy of COPD, SEMINAR RED COPD 2023: CLEAR THE BLOCKAGE, Division of Respiratory Medicine , Department of Medicine and Nursing Department (University) (09 Feb 2023 - 09 Feb 2023)
  23. Overview of Roles of Re-Engineered Discharge (RED) COPD Educators, SEMINAR RED COPD 2023: CLEAR THE BLOCKAGE, Division of Respiratory Medicine , Department of Medicine and Nursing Department (University) (09 Feb 2023 - 09 Feb 2023)
  24. Management of Tuberculosis among Healthcare Workers, TOWARDS VISION ZERO CONFERENCE 2022, University Malaya Medical Centre (UMMC) and Social Security Organization (SOCSO) (National) (02 Nov 2022 - 02 Nov 2022)
  25. Diagnosis And Treatment Of Interstitial Lung Diseases, Case Studies: Spirometry Technique And Spirogram Interpretation and Tackling Occupational Pneumoconiosis: The Malaysia Perspective Forum, Technical Update 48 Occupational Lung Diseases: A Review Of Pneumoconiosis, Academy of Occupational and Environmental Medicine, Malaysia (AOEMM) (National) (08 Oct 2022 - 08 Oct 2022)
  26. As a Forum Moderator of Tobacco Harm Reduction, KLNAC 2022 International Conference, National Cancer Society Malaysia, UMCAS, Universiti Malaya and NARCC (National) (03 Oct 2022 - 03 Oct 2022)
  27. Smear negative Pulmonary Tuberculosis, Training of trainers on CPG Management of tuberculosis (4th Edition), Caw. Penilaian Telnologi Kesihatan Bahagian Perkembangan Perubatan & Sektor Kawalan TB dan Kusta Bahagian Kawalan Penyakit (National) (04 Jul 2022 - 05 Jul 2022)
  28. What are we doing different for severe asthma?, Asthma Control Excellence (ACE), 2020, Norvatis Sdn Bhd. and Malaysian Thoracic Society (National) (19 Dec 2020 - 19 Dec 2020)
  29. Pulmonary infection: CAP, UMMC Antibiotic Masterclass 7.0, UMMC (National) (07 Nov 2020 - 07 Nov 2020)
  30. Overview and Management of Tuberculosis (TB), UMSC Multidisciplinary CME talk, UMSC (Private Institution/research Institution/ Non-government Organization (ngo)) (08 Aug 2020 - 08 Aug 2020)
  31. Covid-19: Facts and Myths., UMSC Live on Webinar: Times of Covid-19: Back to work Safely, UMSC (Private Institution/research Institution/ Non-government Organization (ngo)) (11 Jun 2020 - 11 Jun 2020)
  32. 1. Overview of Spirometry in Clinical Practice 2. Data Interpretation Case Discussion 3. Advanced Lung Function Test - Overview , Occupational Lung Diseases and Spirometry Workshop , Academy of Occupational & Environmental Medicine, Malaysia (AEOMM) (National) (07 Mar 2020 - 07 Mar 2020)
EVENT ORGANISER
  1. Introduction to BreatheEasy programme, BreatheEasy Training Workshop , Division of Respiratory Unit and Nursing Department (University) (15 Sep 2020 - 16 Sep 2020)
ORAL PRESENTER
  1. Prevalence and Clinical Outcomes of Viral Pneumonia in the Malaysian Adult Urban Population, Malaysian Thoracic Society Annual Conference 2024, Malaysian Thoracic Society (National) (29 Aug 2024 - 01 Sep 2024)
  2. PREDICTIVE FACTORS FOR LENGTH OF HOSPITAL STAY INVIRAL PNEUMONIA: AN UNDERSTUDIED ADULT POPULATION INMALAYSIA, MTS 2024, Malaysian Thoracic Society (National) (29 Aug 2024 - 01 Sep 2024)
  3. Enhancing Tuberculosis Prevention through Community Engagement and Involvement: A Case Study in Sabah, Malaysia, 12th IPCRG World Conference, The 12th IPCRG World Conference Organising Secretariat (International) (09 May 2024 - 11 May 2024)
  4. Identifying the prevalence of severe asthma in a Malaysian tertiary hospital, APSR Congress 2023, Asia Pacific Society of Respirology (International) (18 Nov 2023 - 18 Nov 2023)
  5. Re-Engineered Discharge for Chronic Obstructive Pulmonary Disease (RED-COPD), Konvensyen Kumpulan Inovatif dan Kreatif Universiti Malaya 2021, Universiti Malaya (University) (21 Dec 2021 - 22 Dec 2021)
  6. Reasons for uncontrolled asthma in patients attending a difficult-to-treat asthma clinic, Asian Pacific Society of Respirology, Asian Pacific Society of Respirology (International) (20 Nov 2021 - 20 Nov 2021)
POSTER PRESENTER
  1. Causes of death among COPD patients in Malaysia: EXACOS-MY study, ERS 2024, European Respiratory Society (International) (07 Sep 2024 - 11 Sep 2024)
  2. Algorithm modelled & applied in Sabah for Smear Negative Pulmonary Tuberculosis (AMASSMENT): The methodology, RESPIRE ASM 2023, RESPIRE (UK) (International) (27 Sep 2023 - 27 Sep 2023)
  3. Persistent respiratory failure in severe COVID-19 patients - A tertiary centre experience in Kuala Lumpur, Malaysia, European Respiratory Society International Congress 2022, European Respiratory Society  (International) (04 Sep 2022 - 06 Sep 2022)
  4. AN AUDIT ON THE MANAGEMENT OF ACUTE PULMONARY EMBOLISM IN UNIVERSITY OF MALAYA MEDICAL CENTRE (UMMC), Malaysian Thoracic Society Congress 2020, Malaysian Thoracic Society (National) (10 Dec 2020 - 13 Dec 2020)
  5. Radiological Progression in Severe Covid-19 Survivors, Malaysian Thoracic Society Congress 2020, Malaysian Thoracic Society (National) (10 Dec 2020 - 13 Dec 2020)
OTHERS
  1. RAPID Decision Leads to Better Outcome (Establishment of pulmonary embolism response team for unstable PE patients), Breakfast@FOM Live Webinar Series (Episode 8), UM (University) (30 Sep 2020 - 30 Sep 2020)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2024) Review of An Article Entitled "The Availability of Drugs for Stable Copd Treatment in China: a Cross-Sectional Survey", International, (Reviewer)
  2. (2024) Proposal Defense, Candidature Defense and Thesis Seminar (Microbiology Department), University, (External Assessor)
  3. (2023) Sebagai Penilai Untuk Tugasan 3 Minute Thesis (3mt) Bagi Kursus Metodologi Penyelidikan, Fakulti Perubatan., University, (Reviewer)
  4. (2022) Review of Manuscript # Mjmhs-2021-1155.R1 Entitled "Smoking, Vaping Behavior, and The Incidence of Depression Among High School Students in Jakarta, Indonesia", International, (Reviewer)
  5. (2021) External Reviewer On Cpg Evali, National, (External Evaluator)
  6. (2020) Review a Case Report manuscript entitled: "Tuberculosis A great mimicker of lung cancer " for Journal of Malaysian Family Physician, (Reviewer)
Contribution to external organisation
  1. (2024) Speaker Liaison Officer for Malaysia National Asthma Copd Preceptorship Conference (Macpc), National, (Resource Person)
  2. (2024) Malaysian Thoracic Society Inhaler Education & Training Steering Committee 2023 Till 2025, National, (Resource Person)
  3. (2023) Chairperson of Case Based Discussion 1: Spn and Mediastinal Staging for Lung Cancer, International, (Resource Person)
  4. (2023) 1st Malaysia Asthma Preceptorship Conference-Organising Committee, National, (Technical Advisor)
  5. (2023) Targeting Epithelial Tslp Pathway - The Navigator to The Ultimate Destination in Severe Asthma Care?, National, (Technical Advisor)
  6. (2023) Mts Congress 2023 Organising Committee as Members of Conference Facilities Committee, National, (Technical Advisor)
  7. (2023) Perbincangan Meja Bulat Mengenai Rang Undang-Undang (Ruu) Kawalan Produk Merokok Demi Kesihatan Awam 2023, National, (Technical Advisor)
  8. (2023) Sponsorship / Promotion Organising Committee Member, International, (Technical Advisor)
  9. (2023) Penasihatjawatankuasa Program 'Seminar Red Copd 2023: Clear Theblockage' Pada 9 Februari 2023, University, (Resource Person)
  10. (2022) External Reviewer of Cpg On Management of Evali, National, (Technical Advisor)
  11. (2022) Resipratory Exit Viva Exam Committee (Revec), National, (Technical Advisor)
  12. (2021) Inhaler Panel of Experts Meeting (I-Poem Malaysia), National, (Expert Advisor)
  13. (2021) Copd Expert Meeting, International, (Expert Advisor)
  14. (2021) Engagement for Primary Care Module for Copd (Primo) Project, National, (Technical Advisor)
  15. (2021) Cpg Management of Tuberculosis (4th Edition), National, (Technical Advisor)
Contribution to event
  1. (2024) Chairperson of Ild Meet The Expert, National, (Panelist/Moderator)
  2. (2023) Meet The Trialist: Targeting Epithelial Tslp Pathway - The Navigator to The Ultimate Destination in Severe Asthma Care?, National, (Panelist/Moderator)
  3. (2023) Chairperson for Case Based Discussion 5: Mediastinal Thoracoscopy, International, (Panelist/Moderator)
  4. (2021) Speaker for Topic On Management of Very Severe Copd and Interstitial Lung Disease, National, (Panelist/Moderator)
  5. (2021) Speaker for Lecture On Post Covid-19 Multidisciplinary Care: An Unmet Need, National, (Panelist/Moderator)
  6. (2021) Speaker for Lecture On General Overview of Allied Health Professionals in Management of Respiratory Diseases, National, (Panelist/Moderator)
  7. (2021) Speaker for Lecture On a Leap in Inhaler Innovation, National, (Panelist/Moderator)
  8. (2021) Organiser and Moderator for The Train The Trainer: Chronic Obstructive Pulmonary Disease Workshop, National, (Event Organiser)
  9. (2021) Speaker for Topic On Advanced Copd Management-Pharmacological and Non-Pharmacological, National, (Panelist/Moderator)
  10. (2021) Patient Centric Approach Towards Lung Cancer Journey, University, (Panelist/Moderator)
  11. (2021) Speaker for Topic Entitled Difficult-to-Treat Asthma Versus Severe Asthma, National, (Panelist/Moderator)
  12. (2021) Speaker for The Talk Entitled Update On Clinical Management of Occupational Lung Diseases, National, (Panelist/Moderator)
  13. (2021) Moderator for The Difficult to Treat Asthma Session, University, (Panelist/Moderator)
  14. (2021) E-Cigarette or Vaping Product Associated Lung Injury (Evali), University, (Panelist/Moderator)
  15. (2021) Speaker for Topic On Lung Cancer, National, (Panelist/Moderator)
  16. (2020) Moderator of The Establishment of Breathing Working Group for Malaysia 2020, National, (Panelist/Moderator)
  17. (2019) Organising Committee for Educators of Red-Copd Workshop 2019, University, (Event Organiser)
  18. (2019) Organiser and Committee Member of Copd Workshop 2019, University, (Event Organiser)
  19. (2019) Advisor, Organising Committee and Speaker of Tb Workshop 2019, University, (Event Organiser)
Media appearance
  1. (2024) Bfm Radio Station Interview On Pneumonia On 12 Nov 2024, National, (Interview)
  2. (2024) Sin Chew Daily Interview On Non Small Cell Lung Cancer 7 Nov 2024, National, (Interview)
  3. (2024) Sin Chew Daily On Copd 26 May 2024, National, (Interview)
  4. (2024) Sin Chew Daily Interview On Post Covid and Pulmonary Rehabilitation 19 May 2024, National, (Interview)
  5. (2024) Sin Chew Daily Interview On Vaccination 12 May 2024, National, (Interview)
  6. (2024) An Interview Article in Sin Chew Daily On 2 Feb 2024 On Causes of Cough., National, (Interview)
  7. (2021) The China Press Interview On Covid-19 Pneumonia, National, (Interview)
  8. (2021) Covid-19 Pneumonia and Post Covid Care in Sin Chew Daily 21-22 June 2021 (Article in Mandarin), National, (Interview)
  9. (2021) Long Haul: Heightened Risk of Multiple Organ Failure Makes After-Care Essential for Covid-19 Patients, National, (Interview)
  10. (2020) Eradicating Tuberculosis by 2035., National, (Interview)
Mentoring
  1. (2024) Subspecialty Fellowship Training, National, (Mentor)

SUPERVISION

Under Graduate Students
  1. (2022) Case write up on respiratory diseases (Xiamen University Malaysia)
  2. (2022) Respiratory Fellowship
  3. (2021) Respiratory Medicine Fellowship
Postgraduate Student
PhD/ Doctoral
  1. (2024) INVESTIGATION OF LIGNO-TM02 AS ADJUNCTIVE THERAPEUTICS FOR RESPIRATORY DISEASES, TAN HAO DONG
  2. (2024) EFFECTIVENESS OF VIDEO OBSERVED THERAPY IN THE MANAGEMENT OF TUBERCULOSIS: A MUTI-DISTRICT RANDOMISED CONTROL TRIAL, KARTIK A/L KALIYANA SUNDARAM
Master
  1. (2024) PREVALENCE OF COGNITIVE DISTORTIONS IN PALLIATIVE CARE PATIENTS, ONG CHEE HO
  2. (2024) DEVELOPING A CLINICAL PATHWAY FOR INPATIENT PULMONARY REHABILITATION IN ACUTE EXACERBATION OF COPD, RAFIDAH BINTI ABD HADI
  3. (2022) LONGITUDINAL STUDY OF BIOPSY-PROVEM NAFLD PATIENTS, CHAN WAH LOONG
  4. (2022) IMPLEMENTING AND OUTPATIENT PULMONARY REHABILITATION PROGRAM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (PRP-COPD) IN UNIVERSITY MALAYA MEDICAL CENTRE: FEASIBILITY STUDY, YASOTHAI A/P SAHADEEVAN
  5. (2022) TO STUDY ALBUMINURIA AND ITS RELATIONSHIP WITH LV SYSTOLIC AND DIASTOLIC DYSFUNCTION AMONG PATIENTS WITH DIABETES, NUR IZYAN DIYANA BT MD NASIR
  6. (2021) THE IMPACT OF DIAGNOSIS DELAY IN THE OUTCOME OF SMEAR NEGATIVE PULMONARY TUBERCULOSIS, NURUL AIMI BINTI ABD GHANI
  7. (2021) PREVALENCE AND FACTORS ASSOCIATED WITH PLEURAL TUBERCULOSIS IN LYMPHOCYTIC PLEURAL EFFUSION, CHARLEEN BLANGKAT ANAK JIM
  8. (2020) Incidence of E-Cigarette or Vaping Product Use Associated Lung Injury (EVALI) among Severe Acute Respiratory Infections (SARI) Patients in University of Malaya Medical Centre (UMMC), Teo Woon Shen (000000339)
  9. (2020) THE IMPACT OF DIAGNOSIS DELAY IN THE OUTCOME OF SMEAR NEGATIVE PULMONARY TUBERCULOSIS, Nurul Aimi Binti Abd Ghani
  10. (2020) Quality of life in Scleroderma Interstitial Lung Disease and its association with clinical parameters as compared to Idiopathic Lung Fibrosis, Thayalan A/L Ponniah
  11. (2020) Diagnosis Challenges of Lymphocytic Pleural Effusion secondary to Pleural Tuberculosis in Intermediate TB Burden Country, Charleen Blangkat Anak Jim